目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 RESEARCH LIMITATIONS
1.7 KEY STAKEHOLDERS
1.8 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.1.2.1 Key primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION
2.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
2.2.3 GROWTH FORECAST
2.2.4 CAGR PROJECTIONS
2.3 DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 GROWTH RATE ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 OPPORTUNITIES FOR PLAYERS IN MRI SYSTEMS MARKET
4.2 EUROPE: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2025 VS. 2030 (USD MILLION)
4.3 NORTH AMERICA: MRI SYSTEMS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
4.4 ASIA PACIFIC: MRI SYSTEMS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
4.5 MRI SYSTEMS MARKET: GEOGRAPHICAL SNAPSHOT

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Public-private partnerships to scale diagnostic imaging landscape
5.2.1.2 Growing prevalence of MSDs and increasing geriatric population to boost demand
5.2.1.3 Integration of iMRI into surgery to catalyze growth of MRI systems market
5.2.2 RESTRAINTS
5.2.2.1 Complex operations and maintenance of MRI systems
5.2.2.2 Premium pricing of MRI systems
5.2.2.3 Global helium shortage
5.2.3 OPPORTUNITIES
5.2.3.1 Emergence of helium-free MRI systems
5.2.3.2 AI integration with MRI technology for process optimization
5.2.4 CHALLENGES
5.2.4.1 Limited capital budgets
5.2.4.2 Dearth of trained and skilled professionals
5.3 PORTER'S FIVE FORCES ANALYSIS
5.4 REGULATORY LANDSCAPE
5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.4.2 REGULATIONS, BY REGION
5.4.2.1 North America
5.4.2.1.1 US
5.4.2.1.2 Canada
5.4.2.2 Europe
5.4.2.3 Asia Pacific
5.4.2.3.1 Japan
5.4.2.3.2 China
5.4.2.3.3 India
5.5 REIMBURSEMENT SCENARIO ANALYSIS
5.5.1 RELEVANT REIMBURSEMENT CODE, BY COUNTRY
5.5.2 REIMBURSEMENT TRENDS, BY REGION, 2022-2024
5.5.2.1 North America
5.5.2.2 Europe
5.5.2.3 Asia Pacific
5.5.2.4 Latin America
5.5.2.5 Middle East & Africa
5.6 ECOSYSTEM ANALYSIS
5.7 VALUE CHAIN ANALYSIS
5.7.1 R&D
5.7.2 RAW MATERIAL PROCUREMENT AND PRODUCT DEVELOPMENT
5.7.3 MARKETING, SALES, AND DISTRIBUTION
5.7.4 AFTERMARKET SERVICES
5.8 SUPPLY CHAIN ANALYSIS
5.8.1 PROMINENT COMPANIES
5.8.2 SMALL AND MEDIUM-SIZED ENTERPRISES
5.8.3 END USERS
5.8.4 SALES AND DISTRIBUTION
5.9 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2022-2024
5.9.2 AVERAGE SELLING PRICE TREND, BY REGION, 2022-2024
5.10 PATENT ANALYSIS
5.11 TRADE ANALYSIS
5.11.1 IMPORT SCENARIO
5.11.2 EXPORT SCENARIO
5.12 TECHNOLOGY ANALYSIS
5.12.1 KEY TECHNOLOGIES
5.12.1.1 Ultrafast imaging technologies
5.12.1.2 Ultra-high-field MRI
5.12.2 COMPLEMENTARY TECHNOLOGIES
5.12.2.1 Advanced coil technology
5.12.2.2 Weight-bearing MRI imaging
5.12.3 ADJACENT TECHNOLOGIES
5.12.3.1 AI and machine learning in MRI imaging
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.14 INVESTMENT & FUNDING SCENARIO
5.15 KEY CONFERENCES AND EVENTS, 2025-2026
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.16.2 KEY BUYING CRITERIA
5.17 CASE STUDY ANALYSIS
5.17.1 EXPANDING ACCESS TO MRI SYSTEMS
5.18 MRI SCAN APPLICATIONS, 2022-2024
5.19 IMPACT OF AI ON MRI SYSTEMS MARKET
5.19.1 INTRODUCTION
5.19.2 MARKET POTENTIAL OF MRI SYSTEMS
5.19.3 KEY COMPANIES IMPLEMENTING AI
5.19.4 FUTURE OF AI IN MRI SYSTEMS MARKET ECOSYSTEM
5.20 US TARIFF 2025
5.20.1 INTRODUCTION
5.20.2 KEY TARIFF RATES
5.20.3 PRICE IMPACT ANALYSIS
5.20.4 IMPACT ON COUNTRY/REGION
5.20.4.1 US
5.20.4.2 Europe
5.20.4.3 Asia Pacific
5.20.5 IMPACT ON END USE INDUSTRIES

6 MRI SYSTEMS MARKET, BY APPLICATION
6.1 INTRODUCTION
6.2 BRAIN & NEUROLOGICAL MRI
6.2.1 RISE IN NEURODEGENERATIVE DISEASES TO DRIVE MARKET
6.3 SPINE & MUSCULOSKELETAL MRI
6.3.1 GROWING PREVALENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE MARKET
6.4 VASCULAR MRI
6.4.1 USE OF VASCULAR MRI AS ALTERNATIVE TO CT TO SUPPORT MARKET GROWTH
6.5 PELVIC & ABDOMINAL MRI
6.5.1 NEED FOR DETECTING PROSTATE AND CERVICAL CANCERS TO PROPEL MARKET
6.6 BREAST MRI
6.6.1 GROWING AWARENESS REGARDING EARLY BREAST CANCER SCREENING TO DRIVE MARKET
6.7 CARDIAC MRI
6.7.1 RISING INCIDENCE OF CVD TO SUPPORT MARKET GROWTH
6.8 PEDIATRIC MRI
6.8.1 NEED FOR EFFICIENT DIAGNOSTIC ACCURACY AND EARLY DETECTION TO PROMOTE USE OF PEDIATRIC MRI
6.9 OTHER APPLICATIONS

7 MRI SYSTEMS MARKET, BY ARCHITECTURE
7.1 INTRODUCTION
7.2 CLOSED MRI SYSTEMS
7.2.1 STANDARD BORE MRI SYSTEMS
7.2.1.1 High accuracy and improved sensitivity of systems to propel market
7.2.2 WIDE-BORE MRI SYSTEMS
7.2.2.1 High-quality MRI images and improved patient comfort to drive market
7.3 OPEN MRI SYSTEMS
7.3.1 USE OF OPEN MRI SYSTEMS FOR CHILDREN AND OBESE PATIENTS TO DRIVE MARKET

8 MRI SYSTEMS MARKET, BY DESIGN
8.1 INTRODUCTION
8.2 FIXED/STATIONARY MRI SYSTEMS
8.2.1 FLOOR-FIXED MRI SYSTEMS
8.2.1.1 High flexibility and low initial installation costs to drive demand
8.2.2 CEILING-FIXED MRI SYSTEMS
8.2.2.1 Need for MRI systems with high stability and more space to drive market
8.3 PORTABLE MRI SYSTEMS
8.3.1 ADOPTION OF PORTABLE/MOBILE MRI SYSTEMS DUE TO THEIR COST-EFFECTIVENESS AND FLEXIBILITY TO BOOST GROWTH

9 MRI SYSTEMS MARKET, BY FIELD STRENGTH
9.1 INTRODUCTION
9.2 HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS
9.2.1 1.5T
9.2.1.1 Rising use of 1.5T MRI systems for routine examinations to propel market
9.2.2 3T
9.2.2.1 Increasing use of 3T MRI systems to obtain high-quality images to drive market
9.3 LOW-TO-MID-FIELD MRI SYSTEMS
9.3.1 RISING ADOPTION OF OXYGEN-ENHANCED MRI SYSTEMS TO DRIVE MARKET
9.4 ULTRA-HIGH-FIELD MRI SYSTEMS
9.4.1 RISING INNOVATION AND ADVANCEMENTS TO SUPPORT DEMAND FOR ULTRA-HIGH-FIELD SYSTEMS

10 MRI SYSTEMS MARKET, BY END USER
10.1 INTRODUCTION
10.2 HOSPITALS
10.2.1 INCREASING ADOPTION OF ADVANCED MRI SYSTEMS TO PROPEL MARKET
10.3 DIAGNOSTIC IMAGING CENTERS
10.3.1 RISING DEVELOPMENT OF PRIVATE IMAGING CENTERS TO FUEL MARKET
10.4 OTHER END USERS

11 MRI SYSTEMS MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
11.2.2 US
11.2.2.1 Strategic reforms in reimbursements and partnerships to drive market
11.2.3 CANADA
11.2.3.1 Progressive government policies and growing pulse of diagnostic imaging to spur market
11.3 EUROPE
11.3.1 EUROPE: MACROECONOMIC OUTLOOK
11.3.2 GERMANY
11.3.2.1 Digital push in healthcare access and supportive government policies to drive market
11.3.3 UK
11.3.3.1 Strategic developments in diagnostic imaging niche to propel market
11.3.4 FRANCE
11.3.4.1 Increasing patient population and reforms in MRI coverage policies to boost growth
11.3.5 ITALY
11.3.5.1 Progressive government initiatives and strong corporate collaborations to propel
11.3.6 SPAIN
11.3.6.1 Strategic policy reforms and technological advancements in preclinical MRI to drive market
11.3.7 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
11.4.2 JAPAN
11.4.2.1 Strong healthcare infrastructure and supportive government reimbursement policies to boost growth
11.4.3 CHINA
11.4.3.1 Policy reforms, progressive infrastructure plans, and foreign collaborations to boost market
11.4.4 INDIA
11.4.4.1 Industry collaboration and public-private synergy to expand diagnostic imaging landscape
11.4.5 AUSTRALIA
11.4.5.1 New research initiatives and policy enhancements to promote growth
11.4.6 SOUTH KOREA
11.4.6.1 Supportive government policies to promote growth
11.4.7 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
11.5.2 BRAZIL
11.5.2.1 Increased burden of diseases and growing adoption of healthcare insurance to drive market
11.5.3 MEXICO
11.5.3.1 Industry partnerships to drive market growth
11.5.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
11.6.2 GCC COUNTRIES
11.6.2.1 Favorable government initiatives to contribute to market growth
11.6.3 REST OF MIDDLE EAST & AFRICA
11.6.3.1 Increased adoption of mass spectrometers to contribute to growth

12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 KEY PLAYERS' STRATEGIES/RIGHT TO WIN
12.3 REVENUE SHARE ANALYSIS, 2020-2024
12.4 MARKET SHARE ANALYSIS
12.5 RANKING OF KEY PLAYERS, 2024
12.6 COMPANY VALUATION AND FINANCIAL METRICS
12.7 BRAND/PRODUCT COMPARISON
12.8 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
12.8.1 STARS
12.8.2 PERVASIVE PLAYERS
12.8.3 EMERGING LEADERS
12.8.4 PARTICIPANTS
12.8.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
12.8.5.1 Company footprint
12.8.5.2 Field strength footprint
12.8.5.3 Application footprint
12.8.5.4 End user footprint
12.8.5.5 Region footprint
12.9 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
12.9.1 PROGRESSIVE COMPANIES
12.9.2 RESPONSIVE COMPANIES
12.9.3 DYNAMIC COMPANIES
12.9.4 STARTING BLOCKS
12.9.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2024
12.9.5.1 Detailed list of key startups/SMEs
12.9.5.2 Competitive benchmarking of key startups/SMEs
12.10 COMPETITIVE SCENARIO
12.10.1 PRODUCT LAUNCHES AND APPROVALS
12.10.2 DEALS
12.10.3 EXPANSIONS

13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 SIEMENS HEALTHINEERS
13.1.1.1 Business overview
13.1.1.2 Products offered
13.1.1.3 Recent developments
13.1.1.3.1 Product launches and approvals
13.1.1.3.2 Deals
13.1.1.3.3 Expansions
13.1.1.4 MnM view
13.1.1.4.1 Key strengths/Right to win
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses and competitive threats
13.1.2 KONINKLIJKE PHILIPS N.V.
13.1.2.1 Business overview
13.1.2.2 Products offered
13.1.2.3 Recent developments
13.1.2.3.1 Product launches and approvals
13.1.2.3.2 Deals
13.1.2.3.3 Expansions
13.1.2.4 MnM view
13.1.2.4.1 Key strengths/Right to win
13.1.2.4.2 Strategic choices
13.1.2.4.3 Weaknesses and competitive threats
13.1.3 GE HEALTHCARE
13.1.3.1 Business overview
13.1.3.2 Products offered
13.1.3.3 Recent developments
13.1.3.3.1 Product launches and approvals
13.1.3.3.2 Deals
13.1.3.3.3 Expansions
13.1.3.4 MnM view
13.1.3.4.1 Key strengths/Right to win
13.1.3.4.2 Strategic choices
13.1.3.4.3 Weaknesses and competitive threats
13.1.4 CANON MEDICAL SYSTEMS
13.1.4.1 Business overview
13.1.4.2 Products offered
13.1.4.3 Recent developments
13.1.4.3.1 Product launches and approvals
13.1.4.3.2 Deals
13.1.4.4 MnM view
13.1.4.4.1 Key strengths/Right to win
13.1.4.4.2 Strategic choices
13.1.4.4.3 Weaknesses and competitive threats
13.1.5 FUJIFILM CORPORATION
13.1.5.1 Business overview
13.1.5.2 Products offered
13.1.5.3 Recent developments
13.1.5.3.1 Product launches and approvals
13.1.5.3.2 Deals
13.1.5.4 MnM view
13.1.5.4.1 Key strengths/Right to win
13.1.5.4.2 Strategic choices
13.1.5.4.3 Weaknesses and competitive threats
13.1.6 FONAR CORPORATION
13.1.6.1 Business overview
13.1.6.2 Products offered
13.1.6.3 Recent developments
13.1.6.3.1 Deals
13.1.7 ESAOTE S.P.A
13.1.7.1 Business overview
13.1.7.2 Products offered
13.1.7.3 Recent developments
13.1.7.3.1 Product launches and approvals
13.1.7.3.2 Deals
13.1.8 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.
13.1.8.1 Business overview
13.1.8.2 Products offered
13.1.8.3 Recent developments
13.1.8.3.1 Product launches and approvals
13.1.8.3.2 Deals
13.1.8.3.3 Expansions
13.1.9 ASPECT IMAGING LTD.
13.1.9.1 Business overview
13.1.9.2 Products offered
13.1.10 TIME MEDICAL HOLDING
13.1.10.1 Business overview
13.1.10.2 Products offered
13.1.10.3 Recent developments
13.1.10.3.1 Product launches and approvals
13.1.10.3.2 Deals
13.1.10.3.3 Expansions
13.1.11 NEUSOFT MEDICAL SYSTEMS CO., LTD.
13.1.11.1 Business overview
13.1.11.2 Products offered
13.1.11.3 Recent developments
13.1.11.3.1 Deals
13.1.12 STERNMED GMBH
13.1.12.1 Business overview
13.1.12.2 Products offered
13.1.12.3 Recent developments
13.1.12.3.1 Deals
13.1.13 HYPERFINE, INC.
13.1.13.1 Business overview
13.1.13.2 Products offered
13.1.13.3 Recent developments
13.1.13.3.1 Deals
13.1.14 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.
13.1.14.1 Business overview
13.1.14.2 Products offered
13.1.15 SHENZHEN ANKE HIGH-TECH., LTD.
13.1.15.1 Business overview
13.1.15.2 Products offered
13.2 OTHER PLAYERS
13.2.1 MAGNETICA LTD
13.2.2 AURORA HEALTHCARE US CORP
13.2.3 INNERVISION MRI LTD.
13.2.4 BEIJING WANDONG MEDICAL TECHNOLOGY CO., LTD.
13.2.5 MEDONICA CO., LTD
13.2.6 NEOSCAN SOLUTIONS GMBH
13.2.7 KANGDA INTERCONTINENTAL MEDICAL EQUIPMENT CO., LTD.
13.2.8 MINFOUND MEDICAL SYSTEMS CO., LTD.
13.2.9 SYNAPTIVE MEDICAL
13.2.10 XINGAOYI MEDICAL EQUIPMENT CO., LTD

14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS